1. Market Research
  2. > Pharmaceutical Market Trends
U.S. General Anesthesia Drugs Market by Molecule, route of administration, Supply Chain, Competitive - Analysis Forecast to 2020

U.S. General Anesthesia Drugs Market: Forecast until 2020

  • July 2015
  • 127 pages
  • ID: 3155343
In this report:
The U.S. general anesthesia drugs market is expected to reach USD ##,##.## million by 2020 from USD ##,##.## million in 2015, at a CAGR of ##.##% from 2015 to 2020
In terms of volume, the company's sales for ketamine are expected to reach ##.## kg by 2020 from ##.## kg in 2015, at a CAGR of ##.##% from 2015 to 2020.


Table of Contents

Search Inside

The document breaks down the U.S. general anesthesia drugs market based on molecule and route of administration. On the basis of molecules, the sector is detached into Propofol, Benzodiazepine, Ketamine -Ketamine HCL), and Methohexital Sodium. Propofol is anticipated to be quickest-increasing segment, according to its greater preference and quick onset of action.

On the basis of route of administration, the U.S. general anesthesia drugs market is bifurcated into intravenous and inhalational. The intravenous segment is forecasted to account for the biggest share of the U.S. general anesthesia drugs market in 2015. Greater patient compliance and less number of side effects as distinguished to inhalational anesthetics are driving the increase of this market.

Acquisitions was the most preferred strategy approved by main industry actors in order to rise their market shares and cater to unmet needs.

This business report offers industry insights on the qualitative data, market value, rise of different segments and sub-segments, and major players in this sector. The qualitative data includes several levels of industry analysis including market dynamics (drivers, market restraints, alternatives, and segment risks). The market research also provides market values and info on the increase of different segments in the sector. It focuses on emerging and the high-development segments, high-growth areas, and government actions. The industry report also offers a company profiles section, which comprises basic views on the top players in the U.S. general anesthesia drugs market and their products review, advancements, and strategies adopted to maintain and rise their market shares. The above-mentioned segment research data, current market size, and projection of future trends will facilitate top players and new sector entrants to make the essential decisions regarding product offerings, spatial focus, change in approach, Research and development investments for modernizations in products and technologies, and levels of output in order to remain profitable.

Why Purchasing This Study Can Help You:

This industry report will allow both established firms as well as new entrants/smaller companies to measure the pulse of the sector, which in turn will facilitate these companies, collect a larger market share. Companies obtaining the study can use any one or an aggregation of the below-mentioned three strategies (sector entry, opposing assessment, and market entry).

This study furnishes highlights on the following points:

- Business entry: Exhaustive information on product portfolios of the top actors in the U.S. general anesthesia drugs market. The market research examines the U.S. general anesthesia drugs market by molecule and mode of administration.

- Opposing assessment: In-depth assessment of the market strategies, geographic and industry segments, and product review of the main players in the U.S. general anesthesia drugs market

- Market Entry: Highlighted information about strategic management for entering the U.S. general anesthesia drugs market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Nicolas helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Efficacy Testing Market by Product and Service, Type, Application - Global Forecast to 2022

Efficacy Testing Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • January 2018
  • by MarketsandMarkets

Global efficacy testing market projected to grow at a CAGR of 8.7% during the forecast periodThe efficacy testing market is expected to reach USD 501.6 million by 2022 from USD 330.5 million in 2017, at ...

Contract Research Organization Services Market by Type, Therapeutic Area, End User - Global Forecast to 2023

Contract Research Organization Services Market: Global Forecast until 2023

  • $ 5650
  • Industry report
  • February 2018
  • by MarketsandMarkets

The Contract Research Organization (CRO) services market is projected to grow at a CAGR of 7.6% between 2018 and 2023.The CRO services market is expected to reach USD 56.34 billion by 2023 from USD 39.13 ...

Drug Discovery Informatics Market by Function, Solution, End User - Global Forecast to 2022

Drug Discovery Informatics Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • December 2017
  • by MarketsandMarkets

The global drug discovery informatics market is projected to grow at a CAGR of 11.2%.The global drug discovery informatics market is expected to reach USD 2.84 billion in 2022 from USD 1.67 billion in ...


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on